News
BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares. Se ...
Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, offers diagnostic testing and services globally.
The average one-year price target for Bluejay Diagnostics (NASDAQ:BJDX) has been revised to 61.20 / share. This is an increase of 1,900.00% from the prior estimate of 3.06 dated July 5, 2023. The ...
3d
Fintel on MSNBaird Downgrades Quest Diagnostics (DGX)
Fintel reports that on August 25, 2025, Baird downgraded their outlook for Quest Diagnostics (NYSE:DGX) from Outperform to ...
Citi analyst Patrick Donnelly raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $165 and keeps a Buy rating on the shares post the Q3 report. Integrating LifeLabs was the ...
Explore Cardio Diagnostics Hldgs analyst ratings and price targets (NASDAQ:CDIO) on Benzinga. Stay updated on expert opinions and forecasts for CDIO stock.
The average one-year price target for Co-Diagnostics (NASDAQ:CODX) has been revised to 3.06 / share. This is an increase of 50.00% from the prior estimate of 2.04 dated October 31, 2023. The price ...
Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...
Diagnostics will display a positive SARS-CoV-2 result if two or more targets are detected. Conversely, results are negative if less than two targets are detected. Diagnostic results and detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results